CNR1 and rheumatoid arthritis: Furthermore, Δ9-THCA-A inhibited the expression of inflammatory and catabolic genes on stifle joints; Δ9-THCA-A exerts anti-arthritis activity through the CB1R pathways, highlighting its potential in the treatment of chronic inflammatory diseases such as RA.